Tag: Ophthalmology

ReGenTree begins ARISE-3 trial of RGN-259 eye drops for dry eye syndrome

pharmanewsdaily- May 13, 2019

ReGenTree has initiated a phase 3 clinical trial, called ARISE-3, to evaluate the safety and efficacy of 0.1% RGN-259 eye drops for the treatment of ... Read More

Kodiak enrolls patients for retinal disease drug KSI-301’s phase 1 trial

pharmanewsdaily- September 2, 2018

Clinical trial news : Kodiak Sciences has completed enrollment of patients for a phase 1 safety and tolerability study to evaluate its retinal disease drug ... Read More